Test Overview
Test Methodology
Next gen sequencing
Test Usage
FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status in patients with ovarian cancer
Reference Range *
Interpretive report provided
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Test Details
Days Set Up
Monday - Friday
Analytic Time
14 - 21 days
Soft Order Code
MYRMC
Laboratory
Sendout
Reference Laboratory
Myriad Genetics
Section
Special Testing
Specimen Requirements
Special Handling
There are test kits supplied by the company to be used for shipping the block/slides. Sendouts only has 1 in stock, please contact the company to order kits if needed.
Normal Volume
40 microns of tumor, at least 20% of tumor in the block chosen by a pathologist
Storage Temperature
Ambient
Additional Information
Test performed by Myriad Genetics- Oncology